Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PPP4R3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GHR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JARID2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMTC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WEE2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGFB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GRK5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASH1L-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFEB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LDOC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PYM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A36 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR14J1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01568 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAA30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on